Want to see IN:AARTIPHARM full AI Analyst Report?

Aarti Pharmalabs Limited (AARTIPHARM) Financial Statements

2 Followers

Aarti Pharmalabs Limited Financial Overview

Aarti Pharmalabs Limited's market cap is currently ₹88.26B. The company's EPS TTM is ₹23.51; its P/E ratio is 41.38; and it has a dividend yield of 0.36%. Aarti Pharmalabs Limited is scheduled to report earnings on August 7, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 18.19B	₹ 21.15B	₹ 18.16B	₹ 19.45B	₹ 11.92B
Gross Profit	₹ 9.85B	₹ 9.87B	₹ 3.91B	₹ 4.14B	₹ 3.12B
Operating Income	₹ 2.98B	₹ 3.77B	₹ 2.81B	₹ 2.80B	₹ 1.65B
EBITDA	₹ 3.84B	₹ 4.74B	₹ 3.91B	₹ 3.44B	₹ 1.98B
Net Income	₹ 1.75B	₹ 2.72B	₹ 2.17B	₹ 1.93B	₹ 1.22B
Balance Sheet
Cash & Short-Term Investments	₹ 96.16M	₹ 558.57M	₹ 940.33M	₹ 631.11M	₹ 832.73M
Total Assets	₹ 34.82B	₹ 29.06B	₹ 25.82B	₹ 22.44B	₹ 20.40B
Total Debt	₹ 7.54B	₹ 4.13B	₹ 2.85B	₹ 2.15B	₹ 3.41B
Net Debt	₹ 7.45B	₹ 4.06B	₹ 2.62B	₹ 2.03B	₹ 2.58B
Total Liabilities	₹ 13.57B	₹ 9.16B	₹ 8.25B	₹ 6.86B	₹ 6.53B
Stockholders' Equity	₹ 21.25B	₹ 19.90B	₹ 17.57B	₹ 15.58B	₹ 13.86B
Cash Flow
Free Cash Flow	₹ -1.86B	₹ -704.76M	₹ 175.69M	₹ 1.30B	₹ -1.85B
Operating Cash Flow	₹ 2.62B	₹ 3.32B	₹ 2.16B	₹ 2.50B	₹ -437.04M
Investing Cash Flow	₹ -4.31B	₹ -4.14B	₹ -2.15B	₹ -1.58B	₹ -1.39B
Financing Cash Flow	₹ 1.71B	₹ 654.35M	₹ 97.23M	₹ -1.63B	₹ 2.60B

Currency in INR

Aarti Pharmalabs Limited Earnings and Revenue History

Income Statement >

Aarti Pharmalabs Limited Debt to Assets

Balance Sheet >

Aarti Pharmalabs Limited Cash Flow

Cash Flow >

Aarti Pharmalabs Limited Forecast EPS vs Actual EPS

Earnings >